Here’s our fortnightly wrap of all the news driving ASX health stocks.

Of the ASX’s 134-odd small cap health stocks and of those which were trading on Wednesday, 32 were in positive territory over the last fortnight, 10 were flat and 82 saw their share prices fall.

Code Name Price $ (June 24) 2 week return % 1 year return % Market cap
IMC IMMURON LTD 0.28 261 161 $53,483,868
BPH BPH ENERGY LTD 0.016 113 70 $6,344,814
RAC RACE ONCOLOGY LTD 0.48 57 687 $55,896,016
FTT FACTOR THERAPEUTICS LTD 0.003 33 -20 $4,171,343
ZNO ZOONO GROUP LTD 2.97 30 2375 $485,929,728
PYC PYC THERAPEUTICS LTD 0.12 28 326 $337,114,208
CP1 CANNPAL ANIMAL THERAPEUTICS 0.12 26 -20 $11,175,000
M7T MACH7 TECHNOLOGIES LTD 0.95 22 106 $207,307,824
KZA KAZIA THERAPEUTICS LTD 0.49 22 35 $47,299,184
MEB MEDIBIO LTD 0.007 20 -20 $7,916,443
PAA PHARMAUST LTD 0.155 17 246 $40,772,844
1AD ADALTA LTD 0.095 17 -37 $15,574,833
GLH GLOBAL HEALTH LTD 0.2 14 64 $8,419,664
NTI NEUROTECH INTERNATIONAL LTD 0.009 13 -57 $1,936,941
ELX ELLEX MEDICAL LASERS LTD 0.59 12 8 $84,724,672
PAR PARADIGM BIOPHARMACEUTICALS 3.64 12 165 $795,569,600
AZV AZURE HEALTHCARE LTD 0.078 11 -1 $22,166,738
CAJ CAPITOL HEALTH LTD 0.2475 11 18 $250,536,320
ESE ESENSE-LAB LTD-CDI 0.019 11 5 $3,801,538
CGS COGSTATE LTD 0.34 11 82 $61,252,260
SUD SUDA PHARMACEUTICALS LTD 0.042 11 -71 $5,974,685
RSH RESPIRI LTD 0.09 7 -2 $58,654,332
LSH LIFESPOT HEALTH LTD 0.032 7 -64 $3,097,226
LBT LBT INNOVATIONS LTD 0.19 6 35 $41,219,464
RAP RESAPP HEALTH LTD 0.185 6 -5 $135,997,104
ANP ANTISENSE THERAPEUTICS LTD 0.066 5 32 $32,259,828
IBX IMAGION BIOSYSTEMS LTD 0.033 3 108 $25,138,746
VLS VITA LIFE SCIENCES LTD 0.58 2 -15 $31,367,914
BNO BIONOMICS LTD 0.068 1 21 $37,038,640
OCC ORTHOCELL LTD 0.365 1 -29 $66,491,540
NEU NEUREN PHARMACEUTICALS LTD 1.735 1 48 $174,357,328
PBP PROBIOTEC LTD 1.92 1 23 $139,836,480
NOX NOXOPHARM LTD 0.185 0 -58 $39,442,108
FFC FARMAFORCE LTD 0.07 0 -53 $9,013,969
VBS VECTUS BIOSYSTEMS LTD 0.72 0 106 $17,031,468
MMJ MMJ GROUP HOLDINGS LTD 0.12 0 -51 $27,594,478
IVX INVION LTD 0.008 0 -47 $44,004,852
ACW ACTINOGEN MEDICAL LTD 0.025 0 150 $27,905,784
ADO ANTEOTECH LTD 0.022 0 73 $36,170,000
ALT ANALYTICA LTD 0.002 0 -50 $7,039,225
GTG GENETIC TECHNOLOGIES LTD 0.005 0 -11 $37,568,900
NSB NEUROSCIENTIFIC BIOPHARMACEU 0.17 0 29 $14,109,225
AHX APIAM ANIMAL HEALTH LTD 0.48 -1 4 $55,966,624
PAL PALLA PHARMA LTD 0.785 -2 -21 $98,869,160
RCE RECCE PHARMACEUTICALS LTD 0.74 -2 257 $102,053,840
MVP MEDICAL DEVELOPMENTS INTERNA 7.79 -2 43 $493,488,640
HLA HEALTHIA LTD 1.03 -2 23 $64,925,692
BWX BWX LTD 3.78 -3 93 $468,422,080
SDI SDI LTD 0.72 -3 -15 $85,583,184
ONT 1300 SMILES LTD 5.28 -3 -13 $125,021,864
PSQ PACIFIC SMILES GROUP LTD 1.55 -3 35 $237,949,104
BD1 BARD1 LIFE SCIENCES LTD 0.029 -3 -6 $41,015,552
APH AUSTRALIAN PRIMARY HEMP LTD 0.12 -4 -45 $8,370,617
AGH ALTHEA GROUP HOLDINGS LTD 0.37 -4 -65 $82,825,048
AT1 ATOMO DIAGNOSTICS LTD 0.32 -5 60 $176,739,504
UBI UNIVERSAL BIOSENSORS INC-CDI 0.2 -5 5 $35,492,708
PIQ PROTEOMICS INTERNATIONAL LAB 0.435 -5 23 $40,196,556
ACR ACRUX LTD 0.165 -6 -6 $27,816,280
NYR NYRADA INC-CDI 0.16 -6 -20 $17,501,396
IDT IDT AUSTRALIA LTD 0.16 -6 -3 $38,290,084
CYP CYNATA THERAPEUTICS LTD 0.63 -6 -49 $73,202,504
VHT VOLPARA HEALTH TECHNOLOGIES 1.315 -6 -21 $326,169,504
ATH ALTERITY THERAPEUTICS LTD 0.017 -6 -50 $15,560,370
UCM USCOM LTD 0.2 -7 27 $31,463,950
MVF MONASH IVF GROUP LTD 0.56 -7 -56 $218,195,504
MEM MEMPHASYS LTD 0.054 -7 116 $40,714,588
SKN SKIN ELEMENTS LTD 0.08 -7 82 $25,759,542
OVN OVENTUS MEDICAL LTD 0.33 -7 63 $52,218,440
MX1 MICRO-X LTD 0.13 -7 -40 $46,431,820
ICS ICSGLOBAL LTD 1.9 -7 100 $20,147,636
IHL IMPRESSION HEALTHCARE LTD 0.049 -8 36 $35,793,884
OSL ONCOSIL MEDICAL LTD 0.125 -8 135 $99,852,104
CMP COMPUMEDICS LTD 0.44 -8 -24 $80,609,144
1ST 1ST GROUP LTD 0.034 -8 -49 $14,436,975
IPD IMPEDIMED LTD 0.068 -8 -38 $68,115,416
RHT RESONANCE HEALTH LTD 0.17 -8 83 $75,441,568
ONE ONEVIEW HEALTHCARE PLC-CDI 0.045 -8 -79 $7,794,517
OSX OSTEOPORE LTD 0.45 -8 125 $45,553,724
MXC MGC PHARMACEUTICALS LTD 0.023 -8 -58 $34,663,472
RGS REGENEUS LTD 0.065 -8 -9 $18,058,624
AC8 AUSCANN GROUP HOLDINGS LTD 0.155 -9 -57 $49,142,340
ICR INTELICARE HOLDINGS LTD 0.37 -9 85 $26,243,894
PNV POLYNOVO LTD 2.47 -9 57 $1,613,054,848
TD1 TALI DIGITAL LTD 0.027 -10 80 $20,231,240
TLX TELIX PHARMACEUTICALS LTD 1.27 -10 2 $322,255,680
BOT BOTANIX PHARMACEUTICALS LTD 0.043 -10 -76 $41,826,016
DXB DIMERIX LTD 0.385 -10 353 $69,887,784
GSS GENETIC SIGNATURES LTD 2.03 -11 94 $285,221,984
IMU IMUGENE LTD 0.032 -11 113 $141,631,056
ADR ADHERIUM LTD 0.024 -11 -4 $14,431,324
ATX AMPLIA THERAPEUTICS LTD 0.12 -11 20 $7,975,582
AVH AVITA MEDICAL LTD 0.43 -11 9 $923,120,192
BIT BIOTRON LTD 0.079 -11 24 $54,750,752
OIL OPTISCAN IMAGING LTD 0.039 -11 -19 $18,633,374
IMM IMMUTEP LTD 0.16 -11 -41 $75,582,792
RNO RHINOMED LTD 0.076 -12 -68 $12,775,054
JHC JAPARA HEALTHCARE LTD 0.505 -12 -57 $136,296,144
SOM SOMNOMED LTD 1.33 -12 -7 $109,311,128
CYC CYCLOPHARM LTD 1.31 -12 -12 $103,829,232
VTI VISIONEERING TECH-CDI 0.014 -13 -68 $11,630,295
RHY RHYTHM BIOSCIENCES LTD 0.083 -13 -50 $8,362,250
SVA SIMAVITA LTD-CDI 0.02 -13 18 $11,275,563
S66 STAR COMBO PHARMA LTD 0.415 -14 -41 $56,280,888
HCT HOLISTA COLLTECH LTD 0.125 -14 95 $34,418,636
ALC ALCIDION GROUP LTD 0.155 -14 24 $153,557,584
NC6 NANOLLOSE LTD 0.037 -14 -15 $3,912,750
ZLD ZELIRA THERAPEUTICS LTD 0.054 -14 29 $52,516,532
SCU STEMCELL UNITED LTD 0.012 -14 -20 $7,699,301
PAB PATRYS LTD 0.012 -14 -54 $12,871,084
NXS NEXT SCIENCE LTD 1.29 -15 -67 $228,834,304
BXN BIOXYNE LTD 0.011 -15 -31 $7,041,600
CDX CARDIEX LTD 0.022 -15 -24 $16,570,604
LCT LIVING CELL TECHNOLOGIES LTD 0.011 -15 -58 $6,285,851
PTX PRESCIENT THERAPEUTICS LTD 0.054 -16 38 $21,290,074
JHL JAYEX HEALTHCARE LTD 0.021 -16 -55 $3,703,624
SDX SIENNA CANCER DIAGNOSTICS LT 0.065 -17 30 $25,683,634
PCK PAINCHEK LTD 0.12 -17 -43 $124,262,688
EXL ELIXINOL GLOBAL LTD 0.185 -18 -94 $35,674,856
CAN CANN GROUP LTD 0.925 -18 -52 $130,032,032
MDR MEDADVISOR LTD 0.5 -18 37 $123,343,536
GMV G MEDICAL INNOVATION HOLDING 0.053 -19 -77 $31,861,754
AMT ALLEGRA ORTHOPAEDICS LTD 0.105 -19 17 $10,453,700
OPT OPTHEA LTD 2.72 -19 334 $729,417,536
CPH CRESO PHARMA LTD 0.041 -20 -92 $13,409,470
PGC PARAGON CARE LTD 0.12 -20 -71 $40,546,236
PXS PHARMAXIS LTD 0.068 -21 -73 $26,876,946
THC THC GLOBAL GROUP LTD 0.32 -21 -28 $46,729,116
ANR ANATARA LIFESCIENCES LTD 0.15 -21 -43 $7,478,427
OSP OSPREY MEDICAL INC-CDI 0.011 -21 -87 $16,486,677
AVE AVECHO BIOTECHNOLOGY LTD 0.007 -22 75 $11,182,202
CTE CRYOSITE LTD 0.13 -30 136 $6,091,743
CDY CELLMID LTD 0.13 -30 -21 $16,282,093
MDC MEDLAB CLINICAL LTD 0.14 -32 -61 $37,688,816
DVL DORSAVI LTD 0.01 -33 -82 $2,314,275

 

It was back to the old volatile up one day, down the next stock market game this fortnight.

COVID-19 began digging deeper into the US, with most states but particularly Florida blaming the rise on increased testing and young people being too reckless.

Meanwhile, Australia woke up to outbreaks in Victoria spreading from Melbourne’s moneyed south-east to hipster hotspots in the north and beyond.

So it’s been a rough two weeks for ASX health stocks, which were adored in April and spurned for something more exciting (like super risky travel companies) in May.

Diarrhoea company Immuron (ASX:IMC) smashed it over the last two weeks when it said its US military partner, the Naval Medical Research Center (NMRC), planned to file an investigational new drug (IND) application later this year to develop and clinically evaluate a new drug against campylobacter and ETEC (E-Coli).

They’re planning to launch phase-two clinical studies during the first half of 2021.

A week later the company said it had signed on CSIRO to help with the research.

BPH Energy (ASX:BPH), in addition to an oil and gas project, also owns some medical device IP: 16 per cent of a company that is trying to commercialise a brain function monitor.

That brain anaesthesia response monitor, or BARM as the company calls it, was locked into a licensing deal with Philips Healthcare North America which will let the BARM owners hook into the latter’s monitoring software.

The owner of BARM also made an application to the US Food and Drug Administration (FDA) to say its device is safe, works, and is substantially similar to other devices on the market, which means it won’t have to go through quite the same extended approval process as a brand new device.

Race Oncology (ASX:RAC) capped off a rise from 6c in mid-June last year to 49c after demonstrating the cancer-fighting power of its drug Bisantrene.

In a small phase-two trial of 10 patients with the rare bone cancer called acute myeloid leukemia, 40 per cent showed an objective clinical response. Three patients achieved a partial remission and one achieved a complete remission.

Zoono (ASX:ZNO) shot up again, but this time it wasn’t because of hand sanitiser (even though Victorians are hitting the supermarkets again).

The company’s epic rise since January, when it became one of the first movers in the sanitation game, has culminated in its inclusion in the S&P All Ordinaries index.

The All Ordinaries index is the top 500 companies on the ASX by market cap. Normally it’s only adjusted once a year in March, but the massive volatility triggered by the pandemic that month meant rebalancing happened this quarter instead.

Other health stocks to have ‘made it’ into the list include PYC Therapeutics (ASX:PYC), Resapp (ASX:RAP), Somnomed (ASX:SOM), and Atomo Diagnostics (ASX:AT1).